Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsTransplantation, AutologousLiver TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationWhole-Body IrradiationTransplantation ConditioningKidney TransplantationBone and BonesGraft SurvivalTransplantation ChimeraTissue DonorsAnemia, AplasticLeukemiaBusulfanHeart TransplantationHistocompatibility TestingTransplantation, IsogeneicBone Marrow PurgingHistocompatibilityLung TransplantationStem Cell TransplantationGraft RejectionHematopoietic Stem CellsCyclophosphamideTransplantation ImmunologyImmunosuppressive AgentsRecurrenceTreatment OutcomeBone Marrow DiseasesOrgan TransplantationHematopoiesisCombined Modality TherapyTime FactorsMice, Inbred C57BLHematologic NeoplasmsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteImmunosuppressionRemission InductionBone Marrow ExaminationHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesPancreas TransplantationGraft vs Host ReactionAcute DiseaseLeukemia, MyeloidLymphocyte DepletionBone RemodelingIslets of Langerhans TransplantationSurvival AnalysisLymphoma, Non-HodgkinCell TransplantationBone Marrow NeoplasmsLeukocyte TransfusionTransplantationHLA AntigensCyclosporineT-LymphocytesSevere Combined ImmunodeficiencyChimeraMyelodysplastic SyndromesColony-Forming Units AssayCord Blood Stem Cell TransplantationFollow-Up StudiesActuarial AnalysisHematologic DiseasesSurvival RateLymphocyte TransfusionLiving DonorsAntineoplastic Combined Chemotherapy ProtocolsTransplantation ToleranceCytomegalovirus InfectionsCell DifferentiationPeripheral Blood Stem Cell TransplantationGraft vs Tumor EffectCarmustineBone DensityNuclear FamilyGraft vs Leukemia EffectMelphalanSkin TransplantationCytarabineDisease-Free SurvivalPancytopeniaPostoperative ComplicationsGranulocyte Colony-Stimulating FactorLeukocyte CountMice, Inbred BALB CMultiple MyelomaSpleenTransplantation, HeterotopicEtoposideFlow CytometryLymphoma